Seth Reno work email
- Valid
- Valid
- Valid
Seth Reno personal email
►VALUE PROPOSITION: Leading high-performance teams to successfully bring orphan pharmaceuticals to market by facilitating patient access, catalyzing provider availability, and ensuring payer coverage. ►OVERVIEW:As a multifaceted, uniquely experienced biopharmaceutical managed markets executive, my most recent career record highlights extensive experience leading managed-markets commercial operations. Early on, I decided to plan my career trajectory in a way where I would gain a notably wide array of skills and achievements in the bio/pharmaceutical ecosystem, both in sales and managed markets.I have been fortunate to develop an unusually strong background in the marketing of orphan drugs for rare diseases and genetic disorders, which has led to a passion for this specialized niche of the pharmaceutical industry. I am highly experienced in commercializing expedited approvals in biologic and oncology therapeutic areas.►THERPEUTIC BACKGROUND: Vaccines / Biologicals, Cardiovascular, Respiratory, Pain Management, Infectious Disease, Central Nervous System (CNS), Anesthesia, Woman’s Health, Antiviral►KNOWLEDGE / SKILLS / ABILITIES:● Executive Leadership● Cross-Functional Teams● Sales & Marketing Management ● Product Launch / Life Cycle Management● Branding / Channel Management● Co-Promotion Partnering● Medicare / Medicaid / VA / Commercial● Distribution / Specialty Pharmacy / HUB● Orphan Drugs/ Rare Diseases● Retail / GPO / Trade● Disease Management● MCOs / PBMs / Payer Plans● Hospital Systems / Physician Groups● Provider Relationships ● Access Strategy / Reimbursement ● Pull Through Programs
-
President And CeoArkayli Biopharma, Inc. Feb 2022 - PresentMadison, Wi, UsOur mission is to develop novel medications with precision drug delivery systems to enhance efficacy and maximize safety of treatments for children and adults with vascular anomalies. Our lead product candidate, ARK001, has the potential to be the first FDA-approved non-systemic topical (applied to the skin) treatment for infantile hemangioma (IH). -
PrincipalReno Consulting, Llc. Oct 2019 - PresentA strategic healthcare advisor helping life science companies at all stages of development with commercial strategy, business development and operational efficiency.
-
Commercial AdvisorNeurobo Pharmaceuticals, Inc. Jan 2020 - Jan 2022Boston, Massachusetts, UsNeuroBo is a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases. -
Chief Commercial OfficerGemphire Therapeutics Aug 2015 - Dec 2019Livonia, Mi, UsLed strategic market planning, business development, competitive intelligence and formation of strategic partnerships.Merged with NeuroBo Pharmaceuticals 12/2019 -
Commercial Insights/New Product PlanningAstrazeneca Jan 2015 - Apr 2015Cambridge, Cambridgeshire, Gb• Lead a specialized team of 4 direct reports (senior directors), 10 total staff, in support of new product planning.• Provide insights on commercial assets in preparation for product launches in respiratory, autoimmune, and infectious disease (ID), focusing on “go to market” strategies for biologics:o Cold chain distribution for Caprelsa®, Faslodex®, and Lynparza®, including specialty pharmacy HUB distribution and access services.o ID: Sizing and structure for Synagis® and FluMist® Quadrivalent and strategic support for healthcare professionals, distribution, patient access services, and channel assessment.NOTE: AstraZeneca purchased MedImmune in 2007, though commenced full assimilation in 2014. -
Head Of Commercial OperationsMedimmune Jul 2013 - Dec 2014Gaithersburg, Maryland, Us• Led a team of 10 direct reports (directors / senior directors), 75 total staff, with a mandate to thoroughly integrate the MedImmune and AZ commercial teams following AZ’s acquisition of MedImmune.• Facilitated shift of MedImmune’s focus from primary care to specialty care, including “upskilling” capabilities at MedImmune’s Gaithersburg, MD, site to enhance the ability to commercialize multiple biologics.• Managed commercial sales support for the launches of Myalept® and Lynparza®, as well as submission of several new drug applications (NDA) and biologics applications (BLA); Myalept® was approved and launched within a dramatically short period of 4 months. -
Senior Director, Commercial InsightsMedimmune Jun 2010 - Jul 2013Gaithersburg, Maryland, Us• Led a team of 9 direct reports (directors / senior directors), 24 staff total, supporting MedImmune sales and market operations, providing research, forecasting, sales force effectiveness, and analytics across in-line and emerging brands. • Mandated with providing commercial viability to launch a new drug and created a “New Product Planning” team to provide insights for product launches across a diverse therapeutic portfolio, including oncology (ONC), respiratory and autoimmune (RIA), cardiovascular, metabolic , and infectious disease.• Determined global pricing and market access (GPMA).
-
Brand Insight Director, Dyslipidemia FranchiseAstrazeneca Dec 2007 - Jun 2010Cambridge, Cambridgeshire, Gb• Led a high performance brand insight of 9 direct reports in support of Crestor® across all healthcare provider (HCP), consumer, managed markets and finance teams. • Optimized brand resources to position Crestor® as the fastest growing statin amongst cardiologists and the only branded statin to grow market share over a designated 26-month period. • Led “Designed for Launch” efforts to fully commercialize Certriad®, jointly developed by AZ and Abbot Labs. ★ Award: “2008 Brand Marketing Team of Year” for Crestor® by Medical Marketing Magazine.
-
Leader, Commercial Analytics– Field Support (East)Astrazeneca Jun 2006 - Dec 2007Cambridge, Cambridgeshire, Gb• Led a new team of 9 analysts to develop business solutions for MM and sales to be utilized at the business center level (business centers are full vertical business units placed in geographically strategic locations).• Built a national managed markets (MM) analyst and regional business analyst (RBA) team.• Appointed to AZSM1.07 steering committee for MM lead, tasked with developing tools for the new selling model supported by Cornerstone, an internal business unit specializing in managing pharmaceuticals in late life cycle.• Successfully partnered with brand teams to support pharmacy benefit manager (PBM) contracting strategies.
-
Leader, Commercial Operations – Field Support (National)Astrazeneca Jan 2005 - May 2006Cambridge, Cambridgeshire, Gb• Led a national team of 11 direct reports (managed markets business analysts) in a customer-facing role covering 8 business centers. • Provided business solutions focusing on MM contracting, proactive analysis, and sales tools to a wide array of internal teams: group purchasing organizations and long term care (GPO & LTC), federal, trade, health plan, pharmacy benefit manager (PBM) and regional account director (RAD) teams.• Implemented Crestor® “Big Three PBM” strategy.★ Award: Circle of Excellence, AZ’s highest sales award, for implementation of the Brand Opprortunity tool set.
-
District Sales Manager – Cv/RespiratoryAstrazeneca Mar 2004 - Dec 2004Cambridge, Cambridgeshire, Gb• As a rotational DSM, successfully lead a CV/Respiratory sales team of 9 pharmacy sales specialists.• Implemented a compass export tool that led to a 65% increase in Crestor® target delivery scores (TDS) over an 8 month period in addition to a 2.1% national market share growth. • Managed Crestor® budget for 38 representatives and 5 DSMs in Buffalo, NY.
-
Managed Markets – Senior Mm AnalystAstrazeneca Feb 2003 - Mar 2004Cambridge, Cambridgeshire, Gb• Deployed to Nashville / Tampa business centers to work with the Nexium® brand team as MM lead and undertake numerous initiatives and responsibilities:o Spearheaded BCBS Nexium® pull-through program.o Designed Crestor® sales incentive plans. o Supported 2 account director teams through monthly field visits and conducting quarterly reviews with key customers. o Led analytics training for PSS in residency program – “Territory Planning”. o Established contract service terms for IMS, the world’s largest vendor of pharmaceutical data. o Managed 3 core national projects.★ Awards: 3-time recipient of “Best Practice SVP Awards,” issued by the senior vice president of the business center for demonstrating impact in main areas of responsibility.
-
Hospital 1 Pharmaceutical Sales Specialist – Washington, Dc AreaAstrazeneca Apr 2001 - Dec 2003Cambridge, Cambridgeshire, Gb• Represented CNS and pain and infection (P&I) products to teaching institutions, military accounts, and the VA. • Championed and implemented a customer solutions (CS) marketing program to provide unique marketing and educational pieces tailored to the specific needs of large hospital accounts / health care systems in the Washington D.C. area, including the VA, National Institutes of Health (NIH), and Johns Hopkins. Pieces were input directly into the National Quick List, which made them easily and quickly accessible.
-
Sales Specialist- Northern Virginia AreaWyeth Pharmaceuticals (Now Pfizer) 1997 - 2001• Accounts included hospital systems, VA systems, Government healthcare facilities and research institutions.• Represented Wyeth biologics and vaccines and built relationships across several specialists, including infectious disease, endocrinologists, pediatricians, neonatologists, and pulmonologists, in addition to hospital administrators.
-
Territory Representative-North / Central Virginia Territory / Sales Analyst / Market AnalystWyeth Pharmaceuticals (Now Pfizer) 1990 - 1997
Seth Reno Skills
Seth Reno Education Details
-
University Of DelawareBachelor Of Science (Bs) - Human Resources -
Strayer UniversityMaster Of Business Administration (Mba)
Frequently Asked Questions about Seth Reno
What company does Seth Reno work for?
Seth Reno works for Arkayli Biopharma, Inc.
What is Seth Reno's role at the current company?
Seth Reno's current role is President and CEO.
What is Seth Reno's email address?
Seth Reno's email address is se****@****rma.com
What schools did Seth Reno attend?
Seth Reno attended University Of Delaware, Strayer University.
What are some of Seth Reno's interests?
Seth Reno has interest in Children, Education.
What skills is Seth Reno known for?
Seth Reno has skills like Pharmaceutical Industry, Cross Functional Team Leadership, Product Launch, Pharmaceutical Sales, Sales Effectiveness, Biotechnology, Oncology, Cardiology, Managed Care, Market Access, Gastroenterology, Diabetes.
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial